[1]
“CRISPR/Cas9-Mediated Reprogramming of Medicinal Plants for Enhanced Anti-Cancer Bioactive Compounds ‘Advances in Genome Editing for Plant-Derived Therapeutics’”, JOC, vol. 24, no. 3, pp. 350–356, Sep. 2025, doi: 10.64149/J.Carcinog.24.3.350-356.